Article

Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy (SBMA): Focus on Prevalence in the Indigenous Population of Western Canada

2023-07-20

Abstract excerpt

Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy’s disease, is a debilitating neuromuscular disease characterized by progressive muscular weakness and neuronal degeneration, affecting 1-2 individuals per 100,000 globally. While SBMA is relatively rare, recent studies have shown a significantly higher prevalence of the disease within the indigenous population of Western Canada compared to the genera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 50583db3-8c4e-585a-b6a7-a0c817fbf362
DOI: 10.20944/preprints202307.1409.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy (SBMA): Focus on Prevalence in the Indigenous Population of Western CanadaDOI 10.20944/preprints202307.1409.v1Read

Genetic approaches to the treatment of inherited neuromuscular diseasesSemantic proximity Read

Highly Elevated Prevalence of Spinobulbar Muscular Atrophy in Indigenous Communities in Canada Due to a Founder EffectSemantic proximity Read

Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscleSemantic proximity Read

Molecular Mechanisms and Therapeutics for SBMA/Kennedy's DiseaseSemantic proximity Read

Antisense oligonucleotides and their applications in rare neurological diseasesSemantic proximity Read

Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular DystrophySemantic proximity Read

Kennedy's disease: pathogenesis and clinical approaches.Semantic proximity Read

Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic HorizonsSemantic proximity Read

Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disordersSemantic proximity Read

Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive ReviewSemantic proximity Read

Antisense oligonucleotides and other genetic therapies made simpleSemantic proximity Read

Therapeutic antisense oligonucleotides for movement disordersSemantic proximity Read